论文部分内容阅读
目的:探究乳腺癌保乳术结合新辅助化疗法治疗乳腺癌的临床疗效并作分析。方法:选取从2010年1月至2012年12月期间收治入院的乳腺癌患者40例并通过盲选平均分方法将患者平均分为研究组与对照组;给予对照组乳腺癌改良根治术,给予研究组乳腺癌保乳术结合新辅助化疗法治疗;并持续跟踪随访五年,五年后进行对比分析两组临床疗效。结果:研究组手术相关指标优于对照组,而手术后并发症发生情况低于对照组,P<0.05;跟踪随访两组患者5年,研究组手术后1年、3年、5年生存率明显优于对照组,P<0.05。结论:应用乳腺癌保乳术结合新辅助化疗法治疗乳腺癌的临床疗效明显优于常规乳腺癌改良根治术的临床疗效,值得临床推广应用。
Objective: To investigate the clinical efficacy of breast-conserving surgery combined with neoadjuvant chemotherapy in the treatment of breast cancer. Methods: Forty patients with breast cancer admitted from January 2010 to December 2012 were enrolled. The patients were equally divided into study group and control group by blind selection average method. The control group received modified radical mastectomy, The study group breast conserving surgery combined with neoadjuvant chemotherapy treatment; and follow-up follow-up of five years, five years after the comparative analysis of two groups of clinical efficacy. Results: The operation-related indexes in the study group were superior to those in the control group, while the incidence of postoperative complications was lower than that in the control group (P <0.05). Follow-up was followed up for 5 years. The 1-year, 3-year and 5-year survival rates Significantly better than the control group, P <0.05. Conclusion: The clinical efficacy of breast-conserving surgery combined with neoadjuvant chemotherapy in the treatment of breast cancer is significantly better than that of conventional radical mastectomy. It is worthy of clinical application.